Stephen J. Kish

Active 1976–2025

126
Papers
19,745
Citations
85
h-index
123
i10-index

Citations

Citations per year for Stephen J. Kish1980: 1 citations1981: 3 citations1982: 1 citations1983: 2 citations1984: 7 citations1985: 5 citations1986: 6 citations1987: 6 citations1988: 25 citations1989: 27 citations1990: 31 citations1991: 37 citations1992: 34 citations1993: 44 citations1994: 58 citations1995: 62 citations1996: 70 citations1997: 115 citations1998: 135 citations1999: 190 citations2000: 204 citations2001: 197 citations2002: 176 citations2003: 205 citations2004: 212 citations2005: 156 citations2006: 176 citations2007: 185 citations2008: 189 citations2009: 191 citations2010: 196 citations2011: 214 citations2012: 159 citations2013: 190 citations2014: 148 citations2015: 145 citations2016: 147 citations2017: 145 citations2018: 107 citations2019: 392 citations2020: 402 citations2021: 457 citations2022: 299 citations2023: 214 citations2024: 286 citations2025: 160 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,363 citing papers, 31% of this breakdownUnited Kingdom: 617 citing papers, 8.1% of this breakdownCanada: 571 citing papers, 7.5% of this breakdownGermany: 399 citing papers, 5.2% of this breakdownItaly: 355 citing papers, 4.7% of this breakdownChina: 330 citing papers, 4.3% of this breakdownFrance: 316 citing papers, 4.1% of this breakdownJapan: 246 citing papers, 3.2% of this breakdownAustralia: 227 citing papers, 3% of this breakdownSpain: 212 citing papers, 2.8% of this breakdownNetherlands: 167 citing papers, 2.2% of this breakdownSweden: 153 citing papers, 2% of this breakdown
0%31%Other 21.9%

Fields

  • Medicine45.3%
  • Neuroscience31.3%
  • Biochemistry, Genetics and Molecular Biology15%
  • Psychology2.5%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Nursing1.2%
  • Other2.8%

Topics

  • Parkinson's Disease Mechanisms and Treatments10.4%
  • Neurological disorders and treatments7%
  • Neurotransmitter Receptor Influence on Behavior5.4%
  • Neuroscience and Neuropharmacology Research5.1%
  • Genetic Neurodegenerative Diseases3.7%
  • Mitochondrial Function and Pathology3.6%
  • Other64.8%

Coauthors

All papers

Open in search
  1. Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's Disease

    Authors: , , - New England Journal of Medicine 1988 cited by 1,952

  2. Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms

    Authors: , , , , , , , , , , , , , , , , - JAMA Psychiatry 2023 cited by 144

  3. Frataxin is Reduced in Friedreich Ataxia Patients and is Associated with Mitochondrial Membranes

    Authors: , , , , , , , , , , , , , , , - Human Molecular Genetics 1997 cited by 741

  4. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders

    Authors: , , , , , , , , - Brain 2017 cited by 207

  5. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study

    Authors: , , , , , , , , , , - The Lancet Psychiatry 2018 cited by 238

  6. Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder

    Authors: , , , , , , , , , , , , - JAMA Psychiatry 2017 cited by 202

  7. Brain S‐Adenosylmethionine Levels Are Severely Decreased in Alzheimer's Disease

    Authors: , , - Journal of Neurochemistry 1996 cited by 265

  8. Brain α-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation

    Authors: , , , , , , , , , , - Brain 2009 cited by 208

  9. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease

    Authors: , , , , , , - Brain 2007 cited by 380

  10. Low levels of astroglial markers in Parkinson’s disease: relationship to α-synuclein accumulation

    Authors: , , , , , , , , - Neurobiology of Disease 2015 cited by 110

  11. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining

    Authors: , - Neuroscience 1997 cited by 467

  12. Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder

    Authors: , , , , , , , , , , , - Biological Psychiatry 2020 cited by 60

  13. Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019

    Authors: , , , , , - The Canadian Journal of Psychiatry 2022 cited by 41

  14. Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder

    Authors: , , , , , , , , , , , , - JAMA Psychiatry 2019 cited by 97

  15. Imaging of astrocytes in posttraumatic stress disorder: A PET study with the monoamine oxidase B radioligand [11C]SL25.1188

    Authors: , , , , , , , , , , , , , - European Neuropsychopharmacology 2021 cited by 37

  16. A double-blind placebo-controlled trial of minocycline on translocator protein distribution volume in treatment-resistant major depressive disorder

    Authors: , , , , , , , , - Translational Psychiatry 2021 cited by 18

  17. Brain polyamine levels are altered in Alzheimer's disease

    Authors: , - Neuroscience Letters 1995 cited by 144

  18. Fatty Acid Amide Hydrolase Binding in Brain of Cannabis Users: Imaging With the Novel Radiotracer [11C]CURB

    Authors: , , , , , , , , , , , , - Biological Psychiatry 2016 cited by 82

  19. Greater Monoamine Oxidase A Binding in Perimenopausal Age as Measured With Carbon 11–Labeled Harmine Positron Emission Tomography

    Authors: , , , , , , , , , , , - JAMA Psychiatry 2014 cited by 78

  20. Brain Cytochrome Oxidase in Alzheimer's Disease

    Authors: , , , , , , , , - Journal of Neurochemistry 1992 cited by 533

  21. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease

    Authors: , , , , , , , , , - Neurology 1996 cited by 219

  22. Hereditary form of parkinsonism—dementia

    Authors: , , , , , , , , , - Annals of Neurology 1998 cited by 205

  23. Regional distribution of serotonin transporter protein in postmortem human brain

    Authors: , , , , , , , - Nuclear Medicine and Biology 2005 cited by 176

  24. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?

    Authors: - 2003 cited by 88